Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Pharmacological monitoring of azathioprine therapy.

Reuther LO, Sonne J, Larsen NE, Larsen B, Christensen S, Rasmussen SN, Tofteng F, Haaber A, Johansen N, Kjeldsen J, Schmiegelow K.

Scand J Gastroenterol. 2003 Sep;38(9):972-7.

PMID:
14531535
[PubMed - indexed for MEDLINE]
2.

[Monitoring of thiopurine methyltransferase and thiopurine metabolites to optimize azathioprine therapy in inflammatory bowel disease].

Gisbert JP, González-Lama Y, Maté J.

Gastroenterol Hepatol. 2006 Nov;29(9):568-83. Review. Spanish.

PMID:
17129552
[PubMed - indexed for MEDLINE]
3.

Analytic aspects of monitoring therapy with thiopurine medications.

Armstrong VW, Shipkova M, von Ahsen N, Oellerich M.

Ther Drug Monit. 2004 Apr;26(2):220-6. Review.

PMID:
15228169
[PubMed - indexed for MEDLINE]
4.

Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.

Gearry RB, Barclay ML.

J Gastroenterol Hepatol. 2005 Aug;20(8):1149-57. Review.

PMID:
16048561
[PubMed - indexed for MEDLINE]
5.

Thiopurine therapies: problems, complexities, and progress with monitoring thioguanine nucleotides.

Duley JA, Florin TH.

Ther Drug Monit. 2005 Oct;27(5):647-54. Review.

PMID:
16175140
[PubMed - indexed for MEDLINE]
6.

Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy?

Sanderson J, Ansari A, Marinaki T, Duley J.

Ann Clin Biochem. 2004 Jul;41(Pt 4):294-302. Review.

PMID:
15298741
[PubMed - indexed for MEDLINE]
7.

Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine.

Clunie GP, Lennard L.

Rheumatology (Oxford). 2004 Jan;43(1):13-8. Epub 2003 Oct 17. Review.

PMID:
14566029
[PubMed - indexed for MEDLINE]
Free Article
8.

Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease.

Chouchana L, Narjoz C, Beaune P, Loriot MA, Roblin X.

Aliment Pharmacol Ther. 2012 Jan;35(1):15-36. doi: 10.1111/j.1365-2036.2011.04905.x. Epub 2011 Nov 2. Review.

PMID:
22050052
[PubMed - indexed for MEDLINE]
9.

Optimizing immunomodulator therapy for inflammatory bowel disease.

Dubinsky MC.

Curr Gastroenterol Rep. 2003 Dec;5(6):506-11. Review.

PMID:
14602061
[PubMed - indexed for MEDLINE]
10.

Clinical utility of thiopurine S-methyltransferase genotyping.

Corominas H, Baiget M.

Am J Pharmacogenomics. 2004;4(1):1-8. Review.

PMID:
14987117
[PubMed - indexed for MEDLINE]
11.

Clinical implications of thiopurine methyltransferase--optimization of drug dosage and potential drug interactions.

Lennard L.

Ther Drug Monit. 1998 Oct;20(5):527-31. Review.

PMID:
9780130
[PubMed - indexed for MEDLINE]
12.

[New techniques for optimization of thiopurine therapy in leukemia and transplantation].

Loennechen T, Lysaa RA, Giverhaug T, Sylte I, Mathiesen LE, Aarbakke J.

Tidsskr Nor Laegeforen. 2002 Apr 30;122(11):1107-10. Review. Norwegian.

PMID:
12043054
[PubMed - indexed for MEDLINE]
13.

[Therapeutic drug monitoring of 6-thioguanine nucleotides in paediatric acute lymphoblastic leukaemia: interest and limits].

Fakhoury M, de Beaumais T, Médard Y, Jacqz-Aigrain E; Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique.

Therapie. 2010 May-Jun;65(3):187-93. doi: 10.2515/therapie/2010031. Epub 2010 Aug 11. Review. French.

PMID:
20699069
[PubMed - indexed for MEDLINE]
14.

Role of thiopurine metabolite testing and thiopurine methyltransferase determination in pediatric IBD.

Benkov K, Lu Y, Patel A, Rahhal R, Russell G, Teitelbaum J; NASPGHAN Committee on Inflammatory Bowel Disease.

J Pediatr Gastroenterol Nutr. 2013 Mar;56(3):333-40. doi: 10.1097/MPG.0b013e3182844705. Review. Erratum in: J Pediatr Gastroenterol Nutr. 2013 May;56(5):582.

PMID:
23287804
[PubMed - indexed for MEDLINE]
15.

Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment; a pharmacogenomic test whose time has come.

Ford LT, Berg JD.

J Clin Pathol. 2010 Apr;63(4):288-95. doi: 10.1136/jcp.2009.069252. Review.

PMID:
20354201
[PubMed - indexed for MEDLINE]
16.

[Azathioprine treatment of Crohn disease].

Thomsen MK, Vilien M, Gerner CU.

Ugeskr Laeger. 2000 Jan 17;162(3):323-6. Review. Danish.

PMID:
10680466
[PubMed - indexed for MEDLINE]
17.

Pharmacogenomics of azathioprine and 6-mercaptopurine in gastroenterologic therapy.

Baker DE.

Rev Gastroenterol Disord. 2003 Summer;3(3):150-7. Review.

PMID:
14502119
[PubMed - indexed for MEDLINE]
18.

[Individualized therapy with azathioprine or 6-mercaptopurine by monitoring thiopurine methyl-transferase (TPMT) activity].

Gisbert JP, Gomollón F, Maté J, Pajares JM.

Rev Clin Esp. 2002 Oct;202(10):555-62. Review. Spanish. No abstract available.

PMID:
12361557
[PubMed - indexed for MEDLINE]
19.

The therapeutic use of azathioprine in renal transplantation.

Chan GL, Canafax DM, Johnson CA.

Pharmacotherapy. 1987;7(5):165-77. Review.

PMID:
3324057
[PubMed - indexed for MEDLINE]
20.

Pharmacogenetics for the individualization of treatment of rheumatic disorders using azathioprine.

Seidman EG, Furst DE.

J Rheumatol. 2002 Dec;29(12):2484-7. Review. No abstract available.

PMID:
12465139
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk